Recall Register

Drug recall: Artri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: Plantas medicinales…

Class I FDA enforcement event 93257. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

The recalling firm started this drug recall on 20 Oct 2023. The FDA record names a person as the firm, and this site does not show the name. The firm address in the FDA record is in El Paso, TX. FDA put the recall in Class I. FDA event 93257 has 3 product records. The first FDA enforcement report date is 6 Dec 2023. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

USA Nationwide

Recalling firm

The name is withheld, El Paso, TX.

The FDA record gives the name of a person as the recalling firm. This site does not show the names of persons.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 93257: product records
Recall numberProductQuantityClassStatusReport date
D-0224-2024Artri King Reforzado con Origa y Omega 3 tablets, packaged in 100-count bottles, Manufactured by: Plantas medicinales de Mexico, Melchol Ocampo # 65 Local D, Delegacion Xochimilco CP 16800, Mexico DF, UPC 7 501031 111138235 bottlesClass IOngoing6 Dec 2023
D-0225-2024Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598Class IOngoing6 Dec 2023
D-0226-2024Kuka Flex Forte caplets, packaged in 30-count bottles, Manufactured by: Kukamonga, Gonzalez Ortega No 170 Col Centro, 44100 Guadalajara Jal, UPC 0736640810265300 bottlesClass IOngoing6 Dec 2023

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2023
281
Share of these events in Class I
15%
Product records in this event
3

Official channels

Cite this page

Recall Register. FDA enforcement event 93257. https://recallregister.com/fda/i/93257/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: USA Nationwide
What quantity of product is in FDA event 93257?
The event has 3 product records. The first record gives this quantity: 235 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2023 have the same class?
15% of the 281 drug events that started in 2023 are in Class I.